back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-19 10:24 Tx date 2026-08-19 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Montalbano, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150,033
+22,000 vol $6.82 each |
1,558,139 | |
| Filed 2026-08-17 17:55 Tx date 2026-08-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Yale Freedman (Control or Direction)
|
Common Shares
99 - Correction of information
|
+2,000 vol |
38,945 | |
| Filed 2026-08-17 17:53 Tx date 2026-08-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Maya Freedman (Control or Direction)
|
Common Shares
99 - Correction of information
|
+5 vol |
38,707 | |
| Filed 2026-08-17 17:51 Tx date 2026-08-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Freedman, Joseph Stuart
4 - Director of Issuer
Holder: Harriet Feinstein (Control or Direction)
|
Common Shares
99 - Correction of information
|
-200 vol |
337,710 | |
| Filed 2026-07-17 21:33 Tx date 2026-07-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Thackray, Helen
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2026-07-17 21:32 Tx date 2026-07-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Thackray, Helen
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-17 21:32 Tx date 2026-07-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Thackray, Helen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$378,400
+40,000 vol $9.46 each |
40,000 | |
| Filed 2026-07-17 21:30 Tx date 2026-07-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Thackray, Helen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 12:20 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 12:18 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Bazemore, Robert Jr.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 12:11 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Tambiah, Jeyanesh
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2026-06-30 12:09 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Tambiah, Jeyanesh
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,422,400
+160,000 vol $8.89 each |
160,000 | |
| Filed 2026-06-30 12:02 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2026-06-30 12:01 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 11:56 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$355,600
+40,000 vol $8.89 each |
40,000 | |
| Filed 2026-06-30 11:55 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Pott, Amy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 11:46 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Bazemore, Robert Jr.
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+20,000 vol |
20,000 | |
| Filed 2026-06-30 11:45 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Bazemore, Robert Jr.
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-30 11:44 Tx date 2026-06-25 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Bazemore, Robert Jr.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$355,600
+40,000 vol $8.89 each |
40,000 | |
| Filed 2026-06-30 11:41 Tx date 2026-06-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Bazemore, Robert Jr.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|